These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 15564798

  • 21. Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms.
    Kravchenko J, Akushevich I, Seewaldt VL, Abernethy AP, Lyerly HK.
    Breast Cancer Res Treat; 2011 Jul; 128(2):483-93. PubMed ID: 21225455
    [Abstract] [Full Text] [Related]

  • 22. Shifting breast cancer trends in the United States.
    Anderson WF, Reiner AS, Matsuno RK, Pfeiffer RM.
    J Clin Oncol; 2007 Sep 01; 25(25):3923-9. PubMed ID: 17679726
    [Abstract] [Full Text] [Related]

  • 23. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun 01; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 24. Trends in breast cancer survival in Germany from 1976 to 2008--a period analysis by age and stage.
    Holleczek B, Arndt V, Stegmaier C, Brenner H.
    Cancer Epidemiol; 2011 Oct 01; 35(5):399-406. PubMed ID: 21470930
    [Abstract] [Full Text] [Related]

  • 25. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP, Hoop JG, van Beers M, van Rodijnen N, Pannebakker M, Nap M.
    Cytometry B Clin Cytom; 2005 Mar 01; 64(1):43-52. PubMed ID: 15668953
    [Abstract] [Full Text] [Related]

  • 26. Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis.
    Jatoi I, Chen BE, Anderson WF, Rosenberg PS.
    J Clin Oncol; 2007 May 01; 25(13):1683-90. PubMed ID: 17404367
    [Abstract] [Full Text] [Related]

  • 27. Triple-negative breast cancer in West Virginia.
    Abraham J, Flanagan M, Hazard H, Jubelirer S, Tirona MT, Vona-Davis L.
    W V Med J; 2009 Oct 01; 105 Spec No():54-9. PubMed ID: 19999267
    [Abstract] [Full Text] [Related]

  • 28. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study.
    Wilbur DC, Barrows GH.
    Mod Pathol; 1993 Mar 01; 6(2):114-20. PubMed ID: 8097877
    [Abstract] [Full Text] [Related]

  • 29. Results of 23,810 cases of ductal carcinoma-in-situ.
    Sumner WE, Koniaris LG, Snell SE, Spector S, Powell J, Avisar E, Moffat F, Livingstone AS, Franceschi D.
    Ann Surg Oncol; 2007 May 01; 14(5):1638-43. PubMed ID: 17245612
    [Abstract] [Full Text] [Related]

  • 30. Reduction in late-stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer.
    Helvie MA, Chang JT, Hendrick RE, Banerjee M.
    Cancer; 2014 Sep 01; 120(17):2649-56. PubMed ID: 24840597
    [Abstract] [Full Text] [Related]

  • 31. Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.
    Ma H, Henderson KD, Sullivan-Halley J, Duan L, Marshall SF, Ursin G, Horn-Ross PL, Largent J, Deapen DM, Lacey JV, Bernstein L.
    Breast Cancer Res; 2010 Sep 01; 12(3):R35. PubMed ID: 20565829
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark.
    Anderson WF, Rosenberg PS, Petito L, Katki HA, Ejlertsen B, Ewertz M, Rasmussen BB, Jensen MB, Kroman N.
    Int J Cancer; 2013 Nov 01; 133(9):2201-6. PubMed ID: 23616071
    [Abstract] [Full Text] [Related]

  • 34. Perinatal and postnatal exposures and risk of young-onset breast cancer.
    Diaz-Santana MV, O'Brien KM, D'Aloisio AA, Regalado G, Sandler DP, Weinberg CR.
    Breast Cancer Res; 2020 Aug 13; 22(1):88. PubMed ID: 32791983
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Recent trends of in situ carcinoma of the breast and mammographic screening in the Florence area, Italy.
    Barchielli A, Paci E, Giorgi D.
    Cancer Causes Control; 1999 Aug 13; 10(4):313-7. PubMed ID: 10482490
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers.
    Anderson WF, Chen BE, Brinton LA, Devesa SS.
    Cancer Causes Control; 2007 Dec 13; 18(10):1187-98. PubMed ID: 17823850
    [Abstract] [Full Text] [Related]

  • 40. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database.
    Anderson WF, Chatterjee N, Ershler WB, Brawley OW.
    Breast Cancer Res Treat; 2002 Nov 13; 76(1):27-36. PubMed ID: 12408373
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.